Periodic Reporting for period 1 - IMMUNOSTIM (Novel small molecule activators of the NLRP3 inflammasome as immunostimulants)

Propper immune function protects us from invading pathogens and eliminates cancer cells, while aberrant immune responses can damage our body’s tissues. Diseases connected to too much or too little immunity are an increasing societal challenge. Novel drugs to precisely...